Unadjusted HR1 | aHR2 (95% CI) | Likelihood Ratio test | |
---|---|---|---|
p-value | |||
Gender | 0.41 | ||
Male | 1 | 1 | |
Female | 0.89 (0.65, 1.23) | 0.87 (0.63, 1.2) | |
Age group (years) | 0.28 | ||
18 to 29 | 1 | 1 | |
30 to 34 | 1.43 (0.88, 2.32) | 1.37 (0.84, 2.22) | |
35 to 39 | 1.85 (1.15, 2.97) | 1.67 (1.03, 2.69) | |
40 to 49 | 1.27 (0.78, 2.1) | 1.25 (0.75, 2.07) | |
50 to 70 | 1.44 (0.75, 2.74) | 1.57 (0.82, 3.01) | |
CD4 count (/μL) | <0.0001 | ||
0 to 49 | 1 | 1 | |
50 to 99 | 0.34 (0.21, 0.55) | 0.40 (0.25, 0.64) | |
100 to 200 | 0.29 (0.19, 0.45) | 0.38 (0.25, 0.58) | |
> 200 | 0.22 (0.1, 0.48) | 0.34 (0.16, 0.74) | |
Haemoglobin (g/mL) | 0.0003 3 | ||
Time < 3 months | |||
<8 | 5.35 (2.91, 9.84) | 4.99 (2.69, 9.24) | |
8.1 - 9.9 | 2.98 (1.67, 5.33) | 3.05 (1.71, 5.48) | |
10 - 11.9 (12.9 for men) | 1 | 1 | |
>11.9 (>12.9 for men) | 0.10 (0.23, 0.43) | 0.12 (0.03, 0.52) | |
Time ≥ 3 months | |||
<8 | 2.00 (1.10, 3.70) | 1.88 (1.01, 3.49) | |
8.1 - 9.9 | 1.27 (0.73, 2.20) | 1.33 (0.77, 2.31) | |
10 - 11.9 (12.9 for men) | 1 | 1 | |
>11.9 (>12.9 for men) | 0.50 (0.29, 0.86 | 0.59 (0.34, 1.02) |